Pharma & Healthcare
Lanreotide Injection
- Types
- Sustained Release Formulation · Long-acting Formula
- Applications
- Hospital · Clinic · Others
5 editions21 December 2025
Compare the product scope, applications and research editions relevant to your next decision.
Pharma & Healthcare
5 editions21 December 2025
Pharma & Healthcare
5 editions19 December 2025
Pharma & Healthcare
5 editions20 December 2025
Pharma & Healthcare
5 editions19 December 2025
Pharma & Healthcare
5 editions19 December 2025
Pharma & Healthcare
5 editions22 December 2025
Pharma & Healthcare
5 editions21 December 2025
Pharma & Healthcare
5 editions23 December 2025
Pharma & Healthcare
5 editions30 December 2025
Pharma & Healthcare
5 editions19 December 2025
Pharma & Healthcare
Asparaginase is an enzyme, as a medication it is used to treat acute lymphoblastic leukemia (ALL), acute myeloid leukemia (AML), and non-Hodgkin's lymphoma. It is given by injection into a vein, muscle, or under the skin. A pegylated version is also available. Asparaginase was approved for medical use in the United States in 1978. It is on the World Health Organization's List of Essential Medicines, the most effective and safe medicines needed in a health system.
5 editions1 January 2026
Pharma & Healthcare
5 editions22 December 2025